Shubham Singh is a Business Journalist at Business Today. He specializes in diverse areas including sports, healthcare technology, and medical innovations, often exploring themes such as digital health and marketing technology. Shubham's work has been featured in various reputable publications, including .IE, The New Indian Express, and Yahoo Sports.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Shubham Singh's coverage primarily revolves around local events and sports, with a focus on basketball, NBA, and wrestling. He also covers entertainment news to some extent.
Considering his interest in sports and celebrity news, he is likely to respond well to pitches related to local sporting events or profiles of athletes from Andhra Pradesh. For entertainment news, he may be interested in stories about celebrities from the region or unique cultural events.
Given Shubham's geographic focus on India, particularly Andhra Pradesh, pitching stories that align with this geographical scope could increase the chances of successful engagement with him.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Introduction
By: Shubham Singh, Jul By
Viz.ai is expanding beyond acute care into neurodegenerative disease, partnering with Cortechs.ai to bring quantitative brain MRI analysis into its 2,000-hospital network — with MS as the entry point and broader ambitions to follow.
By: Shubham Singh
By July 28, 2026 SE Ranking vs Semrush is a continuous debate among intermediate digital marketers that continues to exist.
By: Shubham Singh, Jul By
GE HealthCare posted its strongest orders quarter since its 2023 spinoff, with an 11.1% organic rise and a $23.9bn backlog, and flagged that much of the growth will convert to revenue in 2027.
By: Shubham Singh, Jul By
Dexcom lifted its full-year revenue guidance to $5.18bn–$5.25bn after a broad-based Q2 beat, with executives pointing to US patient growth, new international tenders and a Medicare expansion timeline targeting mid-2027.
By: Shubham Singh
How to Set Up a Free Custom Domain Email with Zoho Mail, Cloudflare, and Your Own Domain A...
By: Shubham Singh
Penumbra's THUNDERBOLT system hit its reperfusion target with margin in the THUNDER IDE study, but the single-arm design and reliance on a predicate-derived benchmark leave some questions about how the numbers compare to existing devices.
By: Shubham Singh
KKR's $5.7bn take-private of Integer Holdings reflects a broader private equity push into medtech, with depressed valuations and non-cyclical revenue making device contract manufacturers an increasingly attractive target for financial sponsors.
By: Shubham Singh
Xeltis has closed €70m in combined financing to pursue FDA approval for its bioresorbable dialysis access graft, but chief executive Eliane Schutte was candid that the money funds the regulatory path — not the commercial one.
By: Marion Webb, Brian Bossetta, Shubham Singh
Science Corp.'s PRIMA brain-computer interface receives CE mark for restoring central vision in AMD patients. Viz.ai partners with Cortechs.ai on MS tracking. AMA urges Congress to regulate mental health AI chatbots. MedLink earns Mayo Clinic Platform qualification.
